Head-To-Head Analysis: Utah Medical Products (NASDAQ:UTMD) versus CapsoVision (NASDAQ:CV)

Utah Medical Products (NASDAQ:UTMD – Get Free Report) and CapsoVision (NASDAQ:CV – Get Free Report) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, earnings, analyst recommendations, institutional ownership and profitability.

Valuation & Earnings

This table compares Utah Medical Products and CapsoVision”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Utah Medical Products $38.52 million 5.94 $11.29 million $3.34 21.55
CapsoVision $13.55 million 22.27 -$25.32 million ($0.47) -12.83

Utah Medical Products has higher revenue and earnings than CapsoVision. CapsoVision is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Utah Medical Products has a beta of 0.38, suggesting that its share price is 62% less volatile than the S&P 500. Comparatively, CapsoVision has a beta of -2.34, suggesting that its share price is 334% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent recommendations and price targets for Utah Medical Products and CapsoVision, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Utah Medical Products 0 1 0 0 2.00
CapsoVision 1 1 2 0 2.25

CapsoVision has a consensus price target of $9.50, suggesting a potential upside of 57.55%. Given CapsoVision’s stronger consensus rating and higher probable upside, analysts clearly believe CapsoVision is more favorable than Utah Medical Products.

Profitability

This table compares Utah Medical Products and CapsoVision’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Utah Medical Products 30.48% 8.83% 8.59%
CapsoVision -210.09% -188.10% -139.99%

Institutional and Insider Ownership

69.6% of Utah Medical Products shares are held by institutional investors. 8.0% of Utah Medical Products shares are held by insiders. Comparatively, 2.3% of CapsoVision shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Utah Medical Products beats CapsoVision on 10 of the 14 factors compared between the two stocks.

About Utah Medical Products

(Get Free Report)

Utah Medical Products, Inc. develops, manufactures and markets medical devices, with a focus on disposable products used in obstetrics, gynecology and neonatal care. Its offerings include devices and accessories for fetal monitoring, labor and delivery, newborn care and related clinical procedures. Founded in 1978 and headquartered in Midvale, Utah, the company also serves other areas of healthcare, including surgery and emergency care. Its products reach customers in the United States and international markets through a combination of direct sales and distribution channels.

About CapsoVision

(Get Free Report)

CapsoVision develops medical technology for capsule endoscopy, a method of examining the digestive tract using a swallowable camera. Its products are designed to help clinicians visualize the small intestine as part of diagnostic evaluation. The company’s CapsoCam Plus system uses a swallowable capsule with multiple cameras to capture panoramic images as it moves through the small intestine. Images are stored in the capsule and later retrieved for review using the company’s supporting hardware and software.

Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.